COVID-19 Immunity Study


Study participants needed to help find COVID-19 immunotherapy treatment.


The COVID-19 global pandemic is an unprecedented health emergency, and we at QIMR Berghofer, with our extensive history in infectious diseases research, are in a unique position to take up the challenge of urgently needed COVID-19 research across a range of areas.

A key area of our research is discovering how the human immune system fights the disease, so that we can develop drug treatments to help very sick patients. Fighting coronavirus is a global effort and we at QIMR Berghofer are determined to use our advanced skills in immunotherapy development and manufacturing to help. The research team will examine how the immune systems of those who have recovered from COVID-19 responded to the virus with the end goal of developing a new T cell immunotherapy. Thank you for your interest in this exciting new project.


Our researchers are requiring 100 adult volunteer participants who:

  1. Have tested positive for the virus and 
  2. Have subsequently recovered and been released from quarantine

Volunteers should be based in southeast Queensland, as they will need to visit one of eleven participating pathology laboratories in Brisbane, Ipswich or the Gold Coast to provide a blood sample.


Please fill out the form below with your name and email address, and a researcher from QIMR Berghofer’s Translational and Human Immunology Group will contact you directly to answer a brief pre-screening and consent survey. Once that is completed, you will then be asked some follow up questions on demographics, before receiving instructions regarding supplying a blood sample.

To submit an expression of interest in participating in the study, please complete your details in the form below:

QIMR-HREC approval reference: P3618

Recruitment status: OPEN

Open date: May 2020

Close date: ONGOING


Coordinator/s: Professor Corey Smith / Dr Michelle Neller

Please use the Expression of Interest form to register for the study.